Bio Capital Ii Lp Hbm Net Worth

The estimated Net Worth of Bio Capital Ii Lp Hbm is at least $131 Thousand dollars as of 6 November 2017. Bio Hbm owns over 71,428 units of Allena Pharmaceuticals Inc stock worth over $131,066 and over the last 7 years Bio sold ALNA stock worth over $0.

Bio Hbm ALNA stock SEC Form 4 insiders trading

Bio has made over 1 trades of the Allena Pharmaceuticals Inc stock since 2017, according to the Form 4 filled with the SEC. Most recently Bio bought 71,428 units of ALNA stock worth $999,992 on 6 November 2017.

The largest trade Bio's ever made was buying 71,428 units of Allena Pharmaceuticals Inc stock on 6 November 2017 worth over $999,992. On average, Bio trades about 71,428 units every 0 days since 2017. As of 6 November 2017 Bio still owns at least 1,638,330 units of Allena Pharmaceuticals Inc stock.

You can see the complete history of Bio Hbm stock trades at the bottom of the page.

What's Bio Hbm's mailing address?

Bio's mailing address filed with the SEC is Aztec Group House, 11 - 15, Seaton Place, St Helier JE4 0QH, United Kingdom.

Insiders trading at Allena Pharmaceuticals Inc

Over the last 7 years, insiders at Allena Pharmaceuticals Inc have traded over $0 worth of Allena Pharmaceuticals Inc stock and bought 1,537,428 units worth $21,523,992 . The most active insiders traders include Andrew A. F. Hack, James N Topper, and Harbor Master Investors (Ca.... On average, Allena Pharmaceuticals Inc executives and independent directors trade stock every 134 days with the average trade being worth of $15,887. The most recent stock trade was executed by Louis Md Brenner on 15 November 2021, trading 125,582 units of ALNA stock currently worth $10,047.

What does Allena Pharmaceuticals Inc do?

Complete history of Bio Hbm stock trades at Allena Pharmaceuticals Inc

Allena Pharmaceuticals Inc executives and stock owners

Allena Pharmaceuticals Inc executives and other stock owners filed with the SEC include:

• Louis Brenner,
  President, Chief Executive Officer, Director
• Edward Wholihan,
  Chief Financial Officer
• Dr. Louis Brenner,
  Pres, CEO & Director
• Dr. Alexey L. Margolin,
  Co-Founder & Chairman
• Alexey Margolin,
  Chairman of the Board, Co-Founder
• Geoffrey Swire,
  Acting Chief Operating Officer, Interim Principal Operating Officer, Senior Vice President - Corporate Development
• James Topper,
  Independent Director
• Gino Santini,
  Independent Director
• Andrew Hack,
  Independent Director
• Allene Diaz,
  Independent Director
• Robert Alexander,
  Independent Director
• Ann Miller,
  Director
• Stephen Yu,
  Sr. VP of Corp. Quality
• Dr. David J. Clark,
  Chief Medical Officer
• Alicja Januszewicz Ph.D.,
  VP of People & Culture
• Hugh Wight,
  Sr. VP of Technical Operations
• Dr. Richard D. Katz,
  CFO, Principal Financial Officer & Principal Accounting Officer
• Robert Gallotto,
  Co-Founder & Strategic Adviser
• Bio Capital Ii Lp Hbm,
  10% owner
• Robert I Tepper,
  Director
• Vi, L.L.C.Fhm Vi, L.P.Frazi...,
  
• Harbor Master Investors (Ca...,
  10% owner
• Venture Partners Vii L.P.De...,
  
• Stephen Kraus,
  Director
• Rock Ventures Ii, L.P.Third...,
  
• Axel Bolte,
  Director
• Richard D Katz,
  Chief Financial Officer
• Mark J. Fitzpatrick,
  Director